<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03081663</url>
  </required_header>
  <id_info>
    <org_study_id>108949</org_study_id>
    <nct_id>NCT03081663</nct_id>
  </id_info>
  <brief_title>Quadriceps Sparing Versus Standard Total Knee Arthroplasty</brief_title>
  <official_title>Cost and Patient Satisfaction After Total Knee Arthroplasty: Standard Medial Para-patellar Versus Quadriceps Sparing Mid-vastus Surgical Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized clinical trial comparing standard medial para-patellar total knee&#xD;
      arthroplasty with a quadriceps sparing mid-vastus approach. Patients who are medically well&#xD;
      and have a good support structure at home will be randomized to a standard or quadriceps&#xD;
      sparing surgical approach stratified by type of analgesia (adductor canal block or local&#xD;
      infiltration). We will compare patient satisfaction and costs from the perspective of the&#xD;
      Ministry of Health, the institution, society and the patient.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the past 20 years the length of stay in hospital after total knee replacements has&#xD;
      decreased from 9 days to 3 days in Canada and in just the last 10 years the mean length of&#xD;
      stay has decreased by half from 6 to 3 days. In order to discharge patients quicker from&#xD;
      hospital it's been theorized that less invasive techniques and better, longer lasting&#xD;
      anaesthesia are required.&#xD;
&#xD;
      The less invasive quadriceps sparing mid-vastus approach for TKA has been compared to the&#xD;
      standard medial para-patellar technique in many studies. Meta-analyses that have looked at&#xD;
      studies comparing these approaches have shown some early advantages for quadriceps sparing&#xD;
      early post-surgery, but no differences between groups later on and no difference in&#xD;
      complications. Early advantages of the mid-vastus approach could potentially allow for&#xD;
      earlier and safer discharge from hospital.&#xD;
&#xD;
      Adductor canal block (ACB) and local infiltration analgesia (LIA) form the mainstay of opioid&#xD;
      sparing multimodal analgesia for TKA. The nerves of the adductor canal innervate the&#xD;
      superficial and deep tissues of the anterior and medial aspects of the knee. ACB has been&#xD;
      shown to provide equivalent analgesia while maintaining quadriceps power compared to femoral&#xD;
      nerve block (FNB). LIA involves infiltrating the soft tissues of the posterior, lateral and&#xD;
      medial aspects of the knee with local anesthetics, ketorolac and morphine. Due to their&#xD;
      minimal impact on motor function, ACB and LIA are suitable for fast track TKA.&#xD;
&#xD;
      In combination, quadriceps sparing mid-vastus TKA with ACB may allow patients to be&#xD;
      discharged from hospital quicker when compared with standard medial para-patellar TKA with&#xD;
      LIA. With our study we aim to investigate whether a quadriceps sparing TKA can provide cost&#xD;
      savings without changing complication rates when compared to the current standard of care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 11, 2017</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to undergo their surgery through either the quadriceps-sparing mid-vastus approach or the medial para-patellar approach and with or without a tourniquet. We will stratify based on which type of analgesia will be used post-surgery, either an adductor canal block or local infiltration.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants will not be told which group they have been assigned to until they have reached the final follow-up visit for the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Indirect and Direct Costs of Treatment</measure>
    <time_frame>1 year</time_frame>
    <description>ER visits, clinician visits, caregiver lost productivity, tests, etc.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Numeric Rating Scale</measure>
    <time_frame>1 year</time_frame>
    <description>Pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form - 12 (SF-12)</measure>
    <time_frame>1 year</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Western Ontario McMaster Osteoarthritis Index (WOMAC)</measure>
    <time_frame>1 year</time_frame>
    <description>Functional Outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Society Score (KSS)</measure>
    <time_frame>1 year</time_frame>
    <description>Functional Outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol-5D (EQ-5D)</measure>
    <time_frame>1 year</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go Test</measure>
    <time_frame>1 year</time_frame>
    <description>Function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>Falls, wound problems, pulmonary embolism, deep vein thrombosis, infection, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver Assistance Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>Caregiver Confidence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver Strain Index</measure>
    <time_frame>6 weeks</time_frame>
    <description>Caregiver Strain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire</measure>
    <time_frame>2 weeks</time_frame>
    <description>Patient satisfaction</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Quads-Sparing Approach with Tourniquet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will have a navigated total knee arthroplasty with a quadriceps-sparing mid-vastus approach and a tourniquet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medial Para-Patellar with Tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will undergo total knee arthroplasty with a medial para-patellar approach and a tourniquet. An intramedullary femoral guide and extramedullary tibial guide will be used during the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quads-Sparing Approach w/o Tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will have a navigated total knee arthroplasty with a quadriceps-sparing mid-vastus approach and no tourniquet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medial Para-Patellar w/o Tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will undergo total knee arthroplasty with a medial para-patellar approach and no tourniquet. An intramedullary femoral guide and extramedullary tibial guide will be used during the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Quads-Sparing Approach</intervention_name>
    <description>Quadriceps-sparing mid-vastus approach for total knee arthroplasty</description>
    <arm_group_label>Quads-Sparing Approach w/o Tourniquet</arm_group_label>
    <arm_group_label>Quads-Sparing Approach with Tourniquet</arm_group_label>
    <other_name>quads-sparing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Medial Para-Patellar Approach</intervention_name>
    <description>Medial para-patellar approach for total knee arthroplasty</description>
    <arm_group_label>Medial Para-Patellar w/o Tourniquet</arm_group_label>
    <arm_group_label>Medial Para-Patellar with Tourniquet</arm_group_label>
    <other_name>standard</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients requiring primary total knee replacement&#xD;
&#xD;
          -  patients willing and able to comply with follow-up requirements and self-evaluations&#xD;
&#xD;
          -  patients willing to sign an IRB approved informed consent form&#xD;
&#xD;
          -  English fluency (printed instructions are provided in English only)&#xD;
&#xD;
          -  varus arthropathy&#xD;
&#xD;
          -  osteoarthritis&#xD;
&#xD;
          -  ASA less than or equal to 3&#xD;
&#xD;
          -  home/cell phone access&#xD;
&#xD;
          -  adult to accompany patient home post-operatively and to stay with patient for a&#xD;
             minimum period of 1-2 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with inflammatory arthritis&#xD;
&#xD;
          -  patients with a BMI greater than 40 or less than 18&#xD;
&#xD;
          -  patients who are skeletally immature&#xD;
&#xD;
          -  patient with an active infection or suspected latent infection in or about the joint&#xD;
&#xD;
          -  bone stock that is inadequate for support or fixation of the prosthesis&#xD;
&#xD;
          -  hardware precluding intramedullary instrumentation&#xD;
&#xD;
          -  prior osteotomies of the femur or tibia&#xD;
&#xD;
          -  patients living greater than 1.5 hours from the hospital&#xD;
&#xD;
          -  patients without access to caregivers, or unable to go to their home after surgery&#xD;
&#xD;
          -  cognitive or neuromotor conditions&#xD;
&#xD;
          -  patient has significant pain management issues&#xD;
&#xD;
          -  patient/family history of anaesthesia related complications (e.g. malignant&#xD;
             hypothermia, pseudocholinesterase deficiency, airway difficulties, obstructive sleep&#xD;
             apnea)&#xD;
&#xD;
          -  significant psycho/social issues that would prevent the patient from managing at home&#xD;
             safely&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brent A Lanting, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>London Health Sciences Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2017</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Brent Lanting</investigator_full_name>
    <investigator_title>Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>quadriceps sparing mid-vastus</keyword>
  <keyword>medial para-patellar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

